Released on = December 15, 2005, 10:47 am

Press Release Author = 919 Marketing

Industry = Biotech

Press Release Summary = Scott Clark promoted to Vice President of Research and
Development;
Heath Knight joins as Vice President of Business Development



Press Release Body =
Research Triangle Park, North Carolina - December 15, 2005 - Gentris Corporation, a
leading global provider of applied clinical pharmacogenomic services and diagnostic
product solutions, announced today that Scott Clark, Ph.D., has been promoted to
Vice President of Research and Development from the position of Executive Director
of Scientific Affairs. Gentris has also recruited accomplished scientist Heath
Knight, Ph.D., as Vice President of Business Development.

A seasoned expert with over fifteen years experience in pharmacogenomics, Clark will
be responsible for Gentris' scientific strategy and will manage the Clinical
Genetics Research and Development Division. "As Vice President of Research and
Development, Scott will champion the development of the highest quality clinical
pharmacogenomics testing services, so that our company may continue to provide
customers with a greater array of solutions," said Michael Murphy, President and CEO
of Gentris.

Heath Knight, newly appointed Vice President of Business Development, has over
thirteen years experience and has held senior management positions at prominent
contract research organizations, including Lark Technologies, Commonwealth
Biotechnologies, and RTI International. Knight received her doctorate in Human
Genetics from the Medical College of Virginia and conducted post-doctoral training
at Baylor College of Medicine and the Mayo Clinic. "By combining a solid scientific
background with a proven track record for expanding profitable lines and exceeding
sales targets, Heath brings tremendous value and skills to the Vice President of
Business Development position," commented Murphy.

# # #


About Gentris Corporation
Gentris Corporation is a leading global provider of applied clinical pharmacogenomic
services and diagnostic product solutions. As pioneers in the field of
pharmacogenomics, Gentris helps pharmaceutical companies and clinical research
organizations effectively integrate pharmacogenomics into their drug development
programs to deliver safer, more effective compounds to the market sooner. Gentris is
developing diagnostic test kits and validated reference controls that will bring the
promise of personalized medicine to physicians and patients, which will enhance
patient management, improve patients\' response to therapy and revolutionize medicine
through pharmacogenomics. For additional information, please visit
http://www.gentris.com.






Web Site = http://www.gentris.com

Contact Details = Jonathan Jordan
919 Marketing/919.557.7890
jjordan@919marketing.com